X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (748) 748
Publication (101) 101
Book Review (12) 12
Magazine Article (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (375) 375
bradykinin - analogs & derivatives (335) 335
bradykinin (332) 332
animals (329) 329
index medicus (290) 290
male (284) 284
bradykinin - pharmacology (230) 230
pharmacology & pharmacy (188) 188
icatibant (176) 176
female (173) 173
rats (173) 173
bradykinin receptor antagonists (167) 167
bradykinin - therapeutic use (128) 128
hereditary angioedema (126) 126
immunology (113) 113
receptor antagonist (97) 97
bradykinin b2 receptor antagonists (90) 90
angiotensin-converting enzyme inhibitors - pharmacology (89) 89
angioedemas, hereditary - drug therapy (86) 86
angioneurotic edema (86) 86
allergy (85) 85
angioedema (81) 81
adult (80) 80
bradykinin - metabolism (75) 75
angioedema - drug therapy (72) 72
middle aged (72) 72
receptor, bradykinin b2 (72) 72
blood pressure - drug effects (68) 68
management (68) 68
edema (67) 67
kinins (65) 65
antagonist (64) 64
mice (63) 63
treatment outcome (61) 61
rats, sprague-dawley (59) 59
bradykinin - administration & dosage (58) 58
dose-response relationship, drug (56) 56
hoe-140 (52) 52
kallikrein (51) 51
bradykinin - physiology (50) 50
aged (49) 49
angiotensin-converting enzyme inhibitors - adverse effects (49) 49
angiotensin (48) 48
hypertension (48) 48
rats, wistar (48) 48
complement c1 inhibitor protein - therapeutic use (47) 47
bradykinin b2 receptor antagonists - therapeutic use (44) 44
potent (44) 44
disease models, animal (43) 43
medicine, general & internal (42) 42
ace inhibitors (41) 41
allergy and immunology (41) 41
kallikreins - antagonists & inhibitors (41) 41
angioedema - chemically induced (40) 40
c1 inhibitor (40) 40
c1 inhibitor deficiency (40) 40
drug therapy (40) 40
kallikrein-kinin system (40) 40
nitric-oxide (40) 40
peripheral vascular disease (40) 40
receptors (40) 40
ecallantide (39) 39
receptor (39) 39
acute attacks (38) 38
adrenergic beta-antagonists - pharmacology (38) 38
angiotensin receptor antagonists (38) 38
peptides - therapeutic use (38) 38
receptor, bradykinin b2 - metabolism (38) 38
angiotensin-converting enzyme (37) 37
biochemistry & molecular biology (37) 37
diagnosis (37) 37
nitric oxide (37) 37
time factors (37) 37
in vitro techniques (36) 36
angiotensin-converting enzyme inhibitors - therapeutic use (35) 35
enzymes (35) 35
internal medicine (35) 35
anti-inflammatory agents, non-steroidal - therapeutic use (34) 34
inflammation (34) 34
care and treatment (33) 33
guinea pigs (33) 33
papers (33) 33
research (33) 33
attacks (32) 32
bradykinin - antagonists & inhibitors (32) 32
c1 inhibitor concentrate (32) 32
deficiency (32) 32
medicine & public health (32) 32
activation (31) 31
analysis (31) 31
kinins - physiology (31) 31
blood pressure (30) 30
enzyme inhibitors - pharmacology (30) 30
plasma (30) 30
receptors, bradykinin - metabolism (30) 30
antagonists (29) 29
bradykinin - adverse effects (29) 29
pain (29) 29
acting bradykinin-antagonist (27) 27
acute disease (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (734) 734
German (10) 10
French (5) 5
Japanese (3) 3
Chinese (1) 1
Danish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Drug Discovery, ISSN 1474-1776, 10/2008, Volume 7, Issue 10, pp. 801 - 802
  In July 2008, icatibant (Firazyr; Jerini), a bradykinin B2 receptor antagonist, was granted market authorization by the European Commission for the... 
C1 INHIBITOR | POTENT | HEREDITARY ANGIOEDEMA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PHARMACOLOGY & PHARMACY | ACTING BRADYKININ-ANTAGONIST | HOE-140 | Antagonists (Biochemistry) | Angioneurotic edema | Dosage and administration | Drug therapy | Licensing, certification and accreditation | Risk factors
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 418 - 425
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2010, Volume 363, Issue 6, pp. 532 - 541
Journal Article
AUSTRALIAN PRESCRIBER, ISSN 0312-8008, 12/2010, Volume 33, Issue 6, pp. 195 - 196
Journal Article
JOURNAL OF IMMUNOLOGY, ISSN 0022-1767, 07/2018, Volume 201, Issue 2, pp. 343 - 349
Human mast cells (MCs) express a novel G protein-coupled receptor (GPCR) known as Mas-related GPCR X2 (MRGPRX2). Activation of this receptor by a diverse group... 
ACTIVATION | ANTAGONIST | PROTEIN-COUPLED RECEPTOR | ROLES | GENE X2 | HOST-DEFENSE | IMMUNOLOGY | PEPTIDE | MRGX2 | Phenotypes | G protein-coupled receptors | Peptides | Basophilic leukemia | Substance P | Leukemia | Neuropeptides | FDA approval | Inflammatory diseases | Proteins | Bradykinin | Degranulation | Ligands | Cations | Mast cells | Tachykinin | Food | Hemokinin-1 | MRGPRX2 | Human β-defensin-3 | Mast cell | Icatibant | missense variants
Journal Article
CLINICAL AND TRANSLATIONAL ALLERGY, ISSN 2045-7022, 03/2018, Volume 8, Issue 1, pp. 11 - 10
Background: Icatibant is a bradykinin B2-receptor antagonist used for the treatment of hereditary angioedema attacks resulting from C1-inhibitor deficiency.... 
Body mass index | Hereditary angioedema | ALLERGY | Icatibant | Bradykinin | RECEPTOR ANTAGONIST
Journal Article
Formulary, ISSN 1082-801X, 06/2008, Volume 43, Issue 6, p. 188
Journal Article
Allergy, ISSN 0105-4538, 11/2013, Volume 68, Issue 11, pp. 1452 - 1459
Journal Article
International Archives of Allergy and Immunology, ISSN 1018-2438, 07/2015, Volume 167, Issue 1, pp. 21 - 28
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1866 - 1868
To the Editor: Baş et al. (Jan. 29 issue) 1 describe a new therapy for angioedema induced by treatment with an angiotensin-converting–enzyme (ACE) inhibitor,... 
MEDICINE, GENERAL & INTERNAL | Bradykinin - analogs & derivatives | Angioedema - drug therapy | Humans | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Male | Bradykinin B2 Receptor Antagonists - therapeutic use | Patients | Angioedema | Angiotensin | Index Medicus | Abridged Index Medicus
Journal Article